| Literature DB >> 17684612 |
Vladimir Tavares1, Mario Hiroyuki Hirata, Rosario D Crespo Hirata.
Abstract
The peroxisome proliferators-activated receptors (PPARs) are transcription factors belonging to the family of nuclear receptors that regulate glucose homeostasis, lipid metabolism and inflammation. Three proteins, encoded by distinct genes, have been identified: PPARalpha, PPARbeta and PPARgamma, which control gene expression by binding to specific response elements (PPREs) in the promoters. Recent studies suggest that activation of PPARgamma might decrease atherosclerosis progression and increase the insulin sensitivity, might be a potential therapeutic target for the treatment of a diverse array of disorders, including type 2 diabetes and dyslipidaemia. This review highlights recent studies, which have advanced our understanding of the pivotal role that this receptor plays in metabolism, with particular reference to the molecular mechanisms and therapeutic efficacy.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17684612 DOI: 10.1590/s0004-27302007000400005
Source DB: PubMed Journal: Arq Bras Endocrinol Metabol ISSN: 0004-2730